Non-steroidal anti-inflammatory drugs (NSAID)
Phase 3Small molecule
RocheNon-steroidal anti-inflammatory drugs (NSAID) is one of 129 small molecule programs targeting Neck pain. It is currently in Phase 3.
5
Indications
6
Total Trials
4
Active Trials
128
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
357 competitors in Migraine
#DrugCompanyPhaseTrials
1Non-steroidal anti-inflammatory drugs (NSAID)
RochePhase 3
Aimovig
AmgenPreclinical
Emgality
Eli LillyPreclinical
Vyepti
LundbeckPreclinical
Bayer Aspirin
BayerPreclinical
Savella
AbbViePreclinical
Cymbalta
Alnylam PharmaceuticalsPreclinical
Botox
RRevance Therapeutics, Inc.
Preclinical
Adempas
BayerPreclinical
Viagra
VViatris Specialty LLC
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Cesarean Section1 trial
Postoperative in Cesarean Section, the Women Suffering from Pain Due to Wound "incisional Pain", High Level Laser One of Most Effective Methods That Promoting Healing and Decrease Pain so It Will Effective If Use in Decreasing Pain of Cesarian Section
Enrolling by invitation·—·N/A·NCT06793293·40 enrolled
Autoimmune Disease1 trial
Effect of Transcutaneous Electrical Acupoint Stimulation on Dysmenorrhea Among Autoimmune Disease Women
Not yet recruiting·—·N/A·NCT06976151·52 enrolled
Neck pain1 trial
Chiropractic Care, Medication, and Self-Care for Neck Pain
Completed·NNational Center for Complementary and Integrative Health (NCCIH)·Phase 2·NCT00029770·270 enrolled
1 more indication
Migraine1 trial
Effect of Manual Therapy on Migraine in Postmenopausal Women
Not yet recruiting·—·N/A·NCT07127107·40 enrolled
Sources
References
- [1]
- [2]
- [3]
- [4]